| __timestamp | Protagonist Therapeutics, Inc. | Summit Therapeutics Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 1860000 | 6795238 |
| Thursday, January 1, 2015 | 2963000 | 7454247 |
| Friday, January 1, 2016 | 6961000 | 10345862 |
| Sunday, January 1, 2017 | 11779000 | 16984203 |
| Monday, January 1, 2018 | 13697000 | 16187290 |
| Tuesday, January 1, 2019 | 15749000 | 9299233.54 |
| Wednesday, January 1, 2020 | 18638000 | 19232000 |
| Friday, January 1, 2021 | 27196000 | 23611000 |
| Saturday, January 1, 2022 | 31739000 | 26700000 |
| Sunday, January 1, 2023 | 33491000 | 28215000 |
In pursuit of knowledge
In the competitive world of biotechnology, operational efficiency is key. Over the past decade, Summit Therapeutics Inc. and Protagonist Therapeutics, Inc. have navigated the financial landscape with varying strategies. From 2014 to 2023, both companies have seen their Selling, General, and Administrative (SG&A) expenses rise, reflecting their growth and expansion efforts.
Protagonist Therapeutics, Inc. started with a modest SG&A expense in 2014, but by 2023, it had increased by over 1,700%, reaching its peak. Summit Therapeutics Inc., on the other hand, saw a more steady increase, with a 315% rise over the same period. This divergence highlights different strategic approaches: Protagonist's aggressive scaling versus Summit's more measured growth.
As these companies continue to evolve, their SG&A trends offer a window into their operational priorities and market strategies.
Operational Costs Compared: SG&A Analysis of Teva Pharmaceutical Industries Limited and Protagonist Therapeutics, Inc.
Summit Therapeutics Inc. or MannKind Corporation: Who Manages SG&A Costs Better?
Who Optimizes SG&A Costs Better? Alkermes plc or Protagonist Therapeutics, Inc.
PTC Therapeutics, Inc. or Protagonist Therapeutics, Inc.: Who Manages SG&A Costs Better?
Breaking Down SG&A Expenses: MorphoSys AG vs Protagonist Therapeutics, Inc.
Comparing SG&A Expenses: Amicus Therapeutics, Inc. vs Protagonist Therapeutics, Inc. Trends and Insights
Comparing SG&A Expenses: Protagonist Therapeutics, Inc. vs Soleno Therapeutics, Inc. Trends and Insights
Selling, General, and Administrative Costs: Protagonist Therapeutics, Inc. vs Wave Life Sciences Ltd.
Breaking Down SG&A Expenses: Protagonist Therapeutics, Inc. vs Dynavax Technologies Corporation
Protagonist Therapeutics, Inc. or Viridian Therapeutics, Inc.: Who Manages SG&A Costs Better?
Breaking Down SG&A Expenses: Protagonist Therapeutics, Inc. vs Novavax, Inc.
Selling, General, and Administrative Costs: Protagonist Therapeutics, Inc. vs Celldex Therapeutics, Inc.